vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and KEY TRONIC CORP (KTCC). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $96.3M, roughly 1.9× KEY TRONIC CORP). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -8.9%, a 9.8% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -15.4%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $3.1M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -17.8%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Key Tronic Corporation is a technology company founded in 1969 by Lewis G. Zirkle. Its core products initially included keyboards, mice and other input devices. Key Tronic currently specializes in PCBA and full product assembly. The company is among the ten largest contract manufacturers providing electronic manufacturing services in the US. The company offers full product design or assembly of a wide variety of household goods and electronic products such as keyboards, printed circuit board ...
FOLD vs KTCC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $96.3M |
| Net Profit | $1.7M | $-8.6M |
| Gross Margin | 85.7% | 0.6% |
| Operating Margin | 8.6% | -10.7% |
| Net Margin | 0.9% | -8.9% |
| Revenue YoY | 23.7% | -15.4% |
| Net Profit YoY | -88.5% | -74.4% |
| EPS (diluted) | $0.00 | $-0.79 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $96.3M | ||
| Q3 25 | $169.1M | $98.8M | ||
| Q2 25 | $154.7M | $110.5M | ||
| Q1 25 | $125.2M | $112.0M | ||
| Q4 24 | $149.7M | $113.9M | ||
| Q3 24 | $141.5M | $131.6M | ||
| Q2 24 | $126.7M | $126.6M | ||
| Q1 24 | $110.4M | $142.4M |
| Q4 25 | $1.7M | $-8.6M | ||
| Q3 25 | $17.3M | $-2.3M | ||
| Q2 25 | $-24.4M | $-3.9M | ||
| Q1 25 | $-21.7M | $-604.0K | ||
| Q4 24 | $14.7M | $-4.9M | ||
| Q3 24 | $-6.7M | $1.1M | ||
| Q2 24 | $-15.7M | $-2.0M | ||
| Q1 24 | $-48.4M | $-2.2M |
| Q4 25 | 85.7% | 0.6% | ||
| Q3 25 | 88.5% | 8.4% | ||
| Q2 25 | 90.2% | 6.2% | ||
| Q1 25 | 90.7% | 7.7% | ||
| Q4 24 | 90.1% | 6.8% | ||
| Q3 24 | 90.6% | 10.1% | ||
| Q2 24 | 91.1% | 7.2% | ||
| Q1 24 | 87.7% | 5.7% |
| Q4 25 | 8.6% | -10.7% | ||
| Q3 25 | 20.3% | -0.6% | ||
| Q2 25 | -6.1% | -2.1% | ||
| Q1 25 | -6.3% | -0.4% | ||
| Q4 24 | 10.7% | -1.0% | ||
| Q3 24 | 15.3% | 3.4% | ||
| Q2 24 | 11.8% | 0.1% | ||
| Q1 24 | -25.1% | -0.4% |
| Q4 25 | 0.9% | -8.9% | ||
| Q3 25 | 10.2% | -2.3% | ||
| Q2 25 | -15.8% | -3.6% | ||
| Q1 25 | -17.3% | -0.5% | ||
| Q4 24 | 9.8% | -4.3% | ||
| Q3 24 | -4.8% | 0.9% | ||
| Q2 24 | -12.4% | -1.6% | ||
| Q1 24 | -43.9% | -1.6% |
| Q4 25 | $0.00 | $-0.79 | ||
| Q3 25 | $0.06 | $-0.21 | ||
| Q2 25 | $-0.08 | $-0.35 | ||
| Q1 25 | $-0.07 | $-0.06 | ||
| Q4 24 | $0.05 | $-0.46 | ||
| Q3 24 | $-0.02 | $0.10 | ||
| Q2 24 | $-0.05 | $-0.18 | ||
| Q1 24 | $-0.16 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $788.0K |
| Total DebtLower is stronger | $392.7M | $97.7M |
| Stockholders' EquityBook value | $274.2M | $106.2M |
| Total Assets | $949.9M | $325.3M |
| Debt / EquityLower = less leverage | 1.43× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $788.0K | ||
| Q3 25 | $263.8M | $1.1M | ||
| Q2 25 | $231.0M | $1.4M | ||
| Q1 25 | $250.6M | $2.5M | ||
| Q4 24 | $249.9M | $4.2M | ||
| Q3 24 | $249.8M | $6.6M | ||
| Q2 24 | $260.1M | $4.8M | ||
| Q1 24 | $239.6M | $5.3M |
| Q4 25 | $392.7M | $97.7M | ||
| Q3 25 | $392.0M | $100.8M | ||
| Q2 25 | $391.3M | $105.2M | ||
| Q1 25 | $390.7M | $113.6M | ||
| Q4 24 | $390.1M | $111.1M | ||
| Q3 24 | $389.5M | $112.7M | ||
| Q2 24 | $388.9M | $119.5M | ||
| Q1 24 | $388.4M | $125.3M |
| Q4 25 | $274.2M | $106.2M | ||
| Q3 25 | $230.4M | $114.8M | ||
| Q2 25 | $204.3M | $117.1M | ||
| Q1 25 | $193.6M | $119.6M | ||
| Q4 24 | $194.0M | $119.5M | ||
| Q3 24 | $178.8M | $124.3M | ||
| Q2 24 | $132.5M | $124.0M | ||
| Q1 24 | $130.7M | $130.1M |
| Q4 25 | $949.9M | $325.3M | ||
| Q3 25 | $868.8M | $324.6M | ||
| Q2 25 | $815.3M | $315.9M | ||
| Q1 25 | $789.8M | $328.6M | ||
| Q4 24 | $785.0M | $327.8M | ||
| Q3 24 | $786.6M | $355.9M | ||
| Q2 24 | $749.5M | $355.3M | ||
| Q1 24 | $721.8M | $370.1M |
| Q4 25 | 1.43× | 0.92× | ||
| Q3 25 | 1.70× | 0.88× | ||
| Q2 25 | 1.92× | 0.90× | ||
| Q1 25 | 2.02× | 0.95× | ||
| Q4 24 | 2.01× | 0.93× | ||
| Q3 24 | 2.18× | 0.91× | ||
| Q2 24 | 2.93× | 0.96× | ||
| Q1 24 | 2.97× | 0.96× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $6.4M |
| Free Cash FlowOCF − Capex | $16.0M | $3.1M |
| FCF MarginFCF / Revenue | 8.6% | 3.2% |
| Capex IntensityCapex / Revenue | 0.2% | 3.4% |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $11.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $6.4M | ||
| Q3 25 | $35.7M | $7.6M | ||
| Q2 25 | $-26.5M | $8.8M | ||
| Q1 25 | $7.8M | $-1.4M | ||
| Q4 24 | $-3.9M | $1.6M | ||
| Q3 24 | $-23.0M | $9.9M | ||
| Q2 24 | $22.7M | $7.7M | ||
| Q1 24 | $-29.7M | $-3.0M |
| Q4 25 | $16.0M | $3.1M | ||
| Q3 25 | $35.3M | $4.4M | ||
| Q2 25 | $-28.9M | $7.7M | ||
| Q1 25 | $7.5M | $-3.6M | ||
| Q4 24 | $-4.2M | $1.1M | ||
| Q3 24 | $-23.3M | $9.6M | ||
| Q2 24 | $21.6M | $7.1M | ||
| Q1 24 | $-31.5M | $-3.8M |
| Q4 25 | 8.6% | 3.2% | ||
| Q3 25 | 20.9% | 4.5% | ||
| Q2 25 | -18.7% | 7.0% | ||
| Q1 25 | 6.0% | -3.2% | ||
| Q4 24 | -2.8% | 1.0% | ||
| Q3 24 | -16.5% | 7.3% | ||
| Q2 24 | 17.0% | 5.6% | ||
| Q1 24 | -28.5% | -2.7% |
| Q4 25 | 0.2% | 3.4% | ||
| Q3 25 | 0.2% | 3.2% | ||
| Q2 25 | 1.6% | 1.0% | ||
| Q1 25 | 0.2% | 2.0% | ||
| Q4 24 | 0.2% | 0.4% | ||
| Q3 24 | 0.3% | 0.3% | ||
| Q2 24 | 0.9% | 0.4% | ||
| Q1 24 | 1.6% | 0.6% |
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | — | ||
| Q3 24 | — | 8.85× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
KTCC
| Transferred Over Time | $91.3M | 95% |
| Transferred At Point In Time | $5.0M | 5% |
